FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Pharmaneek Inspection Form FDA-483 Out

[ Price : $8.95]

FDA releases the form FDA-483 with two observations from an inspection at the Pharmaneek non-sterile drug manufacturing facility i...

FDA Nixes Enforcement Action Against Whoop's Blood Pressure Feature

[ Price : $8.95]

FDA closes a potential enforcement action against Whoop Inc., reversing an earlier regulatory position that raised questions about...

Expand Real-World Evidence Use in Drug Approvals: Article

[ Price : $8.95]

Drug company executives recommend ways FDA could increase the use of real-world evidence in regulatory decisions.

Guide on Using Quantitative Systems Pharmacology Models for Trial Dosing

[ Price : $8.95]

FDA posts a draft guidance outlining how sponsors can use quantitative systems pharmacology models to determine starting doses for...

FDA Revises Guide on Demonstrating Drug Effectiveness

[ Price : $8.95]

FDA publishes a revised draft guidance that updates how sponsors can demonstrate "substantial evidence" of effectiveness for new d...

Agency Updates Draft Guidance on Master Protocols

[ Price : $8.95]

The agency releases a revised draft guidance aimed at helping sponsors design and conduct clinical trials using master protocols, ...

HHS Unveils Initiative to Accelerate U.S. Clinical Trials

[ Price : $8.95]

HHS unveils a broad, department-wide initiative aimed at speeding clinical research, reducing regulatory barriers, and attracting ...

Regenxbio Gets FDA Agreement to Refile Gene Therapy BLA

[ Price : $8.95]

Regenxbio reaches an agreement with FDA on a path toward a potential accelerated approval of Navsunli (clemidsogene lanparvovec-sn...

How Global Regulators Handle Cancer Drugs After FDA First Approval: Study

[ Price : $8.95]

A new journal article finds substantial differences in how major international regulators evaluate and approve oncology drugs that...